Miran Sebestjen
Department of Angiology
Hospital of Internal Medicine
University Clinical Centre
Ljubljana
Slovenia
Name/email consistency: high
- Role of endothelial function and inflammation in patients with cardiovascular risk factors, with and without a history of myocardial infarction. Sebestjen, M., Sabovic, M., Erzen, B., Simcic, S., Zegura, B., Poredos, P., Keber, I. Cardiology (2007)
- Determinants of endothelial dysfunction and carotid intima-media thickness in combined hyperlipidemia. Sebestjen, M., Zegura, B., Videcnik, V., Keber, I. Coron. Artery Dis. (2005)
- Statin and fibrate treatment of combined hyperlipidemia: the effects on some novel risk factors. Sebestjen, M., Keber, I., Zegura, B., Simcic, S., Bozic, M., Fressart, M.M., Stegnar, M. Thromb. Haemost. (2004)
- Both cerivastatin and fenofibrate improve arterial vasoreactivity in patients with combined hyperlipidaemia. Sebestjen, M., Zegura, B., Keber, I. J. Intern. Med. (2002)
- Simvastatin and pravastatin equally improve flow-mediated dilation in males with hypercholesterolemia. Sebestjen, M., Boh, M., Keber, I. Wien. Klin. Wochenschr. (2002)